Manager, Process Development, Nucleic Acid Therapies

Manager, Process Development, Nucleic Acid Therapies

The Advanced Therapeutics Manufacturing Facility (ATMF) is a new CFI-funded project and a flagship project of Canada’s Immuno-Engineering and Biomanufacturing Hub (CIEBH ), a UBC-led national research hub that aims to align the critical mass of immune-engineering expertise with biomanufacturing and public health strengths concentrated in BC. It is also a key deliverable for the BC MS Cell Therapies Translational Research Network, with the goal of accelerating novel cell therapies for neurological and autoimmune diseases. This multi-year, multi-phase project aims to build a Good Manufacturing Practice (GMP) biomanufacturing core facility to produce advanced therapeutics - such as cells, mRNA vaccines, and ancillary plasmid DNA - essential for early-phase clinical trials, addressing current health challenges, and strengthening Canada’s pandemic preparedness

The Manager, Process Development Nucleic Acids provides seni...